Novel trivalent anti-influenza reagent

Area of Science:

• Medicinal Chemistry
• Virology
• Biochemistry

Background:

• Influenza virus poses a significant global health threat.
• Hemagglutinin (HA) is a key surface protein mediating viral entry.
• Developing novel antiviral agents targeting HA is crucial.

Purpose of the Study:

• To design and synthesize novel trivalent anti-influenza reagents.
• To investigate the interaction mechanism of these reagents with the influenza HA.
• To evaluate the antiviral efficacy of the synthesized compounds.

Main Methods:

• Chemical synthesis of trivalent sialyllactose-conjugated reagents.
• Computer-simulated structural analysis of reagent-HA interaction.
• In vitro plaque reduction assay using influenza A/PR/8/1934 (H1N1) in MDCK cells.

Main Results:

• Novel trivalent anti-influenza reagents were successfully synthesized.
• Structural analysis suggested potential hydrogen bonding interactions with HA.
• One compound exhibited approximately 85% inhibition of viral replication at 400 microM at 4°C.

Conclusions:

• The synthesized trivalent reagents show promise as anti-influenza agents.
• The findings provide insights into the mechanism of HA-ligand interaction.
• Further development could lead to new therapeutic strategies against influenza.